116 related articles for article (PubMed ID: 1624982)
1. Injection sites utilized for DPT immunizations in infants.
Daly JM; Johnston W; Chung Y
J Community Health Nurs; 1992; 9(2):87-94. PubMed ID: 1624982
[TBL] [Abstract][Full Text] [Related]
2. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B
CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449
[TBL] [Abstract][Full Text] [Related]
3. Ventrogluteal area--a suitable site for intramuscular vaccination of infants and toddlers.
Cook IF; Murtagh J
Vaccine; 2006 Mar; 24(13):2403-8. PubMed ID: 16406175
[TBL] [Abstract][Full Text] [Related]
4. DPT vaccine-induced lipoatrophy: an observational study.
Sardana K; Garg VK; Bhushan P; Relhan V; Sharma S
Int J Dermatol; 2007 Oct; 46(10):1050-4. PubMed ID: 17910713
[TBL] [Abstract][Full Text] [Related]
5. Comparison of diphtheria-tetanus-two component acellular pertussis vaccines in United States and Japanese infants at 2, 4, and 6 months of age.
Rothstein EP; Kamiya H; Nii R; Matsuda T; Bernstein HH; Long SS; Hosbach PH; Meschievitz CK
Pediatrics; 1996 Feb; 97(2):236-42. PubMed ID: 8584384
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
Halperin SA; King J; Law B; Mills E; Willems P
Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
[TBL] [Abstract][Full Text] [Related]
7. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
8. Effect of needle change and air bubble in syringe on minor adverse reactions associated with diphtheria-tetanus toxoids-pertussis-polio vaccination in infants.
Ipp M; Goldbach M; Greenberg S; Gold R
Pediatr Infect Dis J; 1990 Apr; 9(4):291-3. PubMed ID: 2336316
[No Abstract] [Full Text] [Related]
9. [The immunogenicity of vaccines against diphtheria, tetanus, pertussis and polio administered orally on the vaccinal calendar at the age of 2, 4 and 6 months and their coadministration with a hepatitis B vaccine at 0, 2 and 6 months].
Arístegui Fernández J; Muñiz Saitua J; Pérez Legorburu A; Imaz Pérez M; Arrate Zugazabeitia JP; Suárez Fernández MD; Goiri Zabala MD
An Esp Pediatr; 1996 Jan; 44(1):25-8. PubMed ID: 8849056
[TBL] [Abstract][Full Text] [Related]
10. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine.
Auerbach BS; Lake AM; Wilson ME; Willingham FF; Shematek J; Moulton L; Deforest A; Halsey NA
Biologicals; 1998 Jun; 26(2):145-53. PubMed ID: 9811522
[TBL] [Abstract][Full Text] [Related]
11. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A
J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
[TBL] [Abstract][Full Text] [Related]
13. Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length.
Ipp MM; Gold R; Goldbach M; Maresky DC; Saunders N; Greenberg S; Davy T
Pediatrics; 1989 May; 83(5):679-82. PubMed ID: 2717284
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.
Diaz-Mitoma F; Halperin SA; Tapiero B; Hoffenbach A; Zappacosta PS; Radley D; Bradshaw S; Martin JC; Boslego JW; Hesley TM; Bhuyan PK; Silber JL
Vaccine; 2011 Feb; 29(6):1324-31. PubMed ID: 21134456
[TBL] [Abstract][Full Text] [Related]
15. Using the ventrogluteal site for intramuscular injections.
Donaldson C; Green J
Nurs Times; 2005 Apr 19-25; 101(16):36-8. PubMed ID: 15871375
[TBL] [Abstract][Full Text] [Related]
16. [Study on immune persistency of combined diphtheria-pertussis-tetanus (DPT) triple vaccine].
Diao L
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Feb; 13(1):26-9. PubMed ID: 1581951
[TBL] [Abstract][Full Text] [Related]
17. The pain response of infants in Turkey to vaccination in different injection sites.
Celebioglu A; Akpinar RB; Tezel A
Appl Nurs Res; 2010 May; 23(2):101-5. PubMed ID: 20420997
[TBL] [Abstract][Full Text] [Related]
18. Optimum needle length for DPT inoculation of Indian infants.
Chugh K; Chawla D; Aggarwal BB
Indian J Pediatr; 1993; 60(3):435-40. PubMed ID: 8253494
[TBL] [Abstract][Full Text] [Related]
19. Reactogenicity of fluid compared with adsorbed diphtheria-pertussis-tetanus vaccine.
Mathias RG
Can Med Assoc J; 1984 Jun; 130(12):1561-5. PubMed ID: 6610469
[TBL] [Abstract][Full Text] [Related]
20. Immunizations to the deltoid region.
Bergeson PS
Pediatrics; 1990 Jan; 85(1):134-5. PubMed ID: 2296483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
